UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): February 15, 2008

                             Dynacq Healthcare, Inc.
             (Exact name of registrant as specified in its charter)


        Nevada                      000-21574                    76-0375477
    (State or other          (Commission File Number)         (I.R.S. Employer
    jurisdiction of                                          Identification No.)
   incorporation or
     organization)

                       10304 Interstate 10 East, Suite 369
                              Houston, Texas 77029
              (Address of principal executive offices and zip code)


                                 (713) 378-2000
              (Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)

[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))





Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) On February 15, 2008, the Board of Directors of Dynacq Healthcare, Inc. (the
"Company") elected Dr. Xiao Li to serve as a director of the Company. Dr. Li was
selected  as a  director  based  on  her  qualifications  as a  board  certified
physician in internal  medicine and her years of  experience  in the  healthcare
industry; there was no arrangement or understanding between Dr. Li and any other
persons  pursuant to which she was  elected.  At this time,  Dr. Li has not been
named to serve as a member of any of the committees of the Board of Directors.

During the fiscal year ended August 31, 2007,  the Company and its  subsidiaries
paid to Dr. Li an aggregate of $188,975, to provide in-house medical services to
the  emergency  room  patients  at  Surgery  Specialty  Hospitals  of  America -
Southeast Houston, its Pasadena Facility.

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                   Dynacq Healthcare, Inc.


                                   By: /s/ Philip S. Chan
                                       ------------------
                                   Philip S. Chan
                                   Chief Financial Officer


Date:  February 22, 2008